Literature DB >> 22611056

Synchronous hepatocellular carcinoma and Castleman's disease: the role of the interleukin-6-signaling pathway.

Yun Shin Chun1, Julien Calderaro, Jessica Zucman-Rossi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22611056     DOI: 10.1002/hep.25857

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.

Authors:  Karine Poussin; Camilla Pilati; Gabrielle Couchy; Julien Calderaro; Paulette Bioulac-Sage; Yannick Bacq; Valérie Paradis; Emmanuelle Leteurtre; Nathalie Sturm; Jeanne Ramos; Catherine Guettier; Armelle Bardier-Dupas; Anais Boulai; Dominique Wendum; Janick Selves; Tina Izard; Jean-Charles Nault; Jessica Zucman-Rossi
Journal:  Oncoimmunology       Date:  2014-01-03       Impact factor: 8.110

2.  Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

Authors:  Mei Zhou; Hong Yang; R Marc Learned; Hui Tian; Lei Ling
Journal:  Nat Commun       Date:  2017-05-16       Impact factor: 14.919

3.  Castleman's disease mimicking lymph node metastases in a young woman with laryngeal cancer.

Authors:  Krystyna Serkies; Małgorzata Łazar-Poniatowska; Joanna Seredyńska; Wojciech Biernat; Jacek Jassem
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20

4.  Molecular classification of hepatocellular adenomas.

Authors:  Jean Charles Nault; Jessica Zucman Rossi
Journal:  Int J Hepatol       Date:  2013-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.